UBTECH Accelerates Walker S2 Output to 5000 Units

Production Capacity Surges

UBTECH Robotics confirmed on April 3, 2026, its commitment to ramp Walker S2 production to 5,000 units annually, directly addressing surging demand from industrial sectors. This move follows the company's activation of expanded assembly lines at its Liuzhou facility, where teams finalized optimizations for high-volume output. By April 7, initial test runs demonstrated seamless scaling, positioning UBTECH ahead of competitors in humanoid deployment.

Recent Contracts Fuel Expansion

Key to this ramp-up, UBTECH secured a 264 million yuan contract on April 5 with authorities in Fangchenggang for Walker S2 robots at the China-Vietnam border, tasked with patrol, guidance, and inspections. This deal builds on a 159 million yuan agreement earlier that week for a Zigong data collection center, pushing cumulative Walker series orders past 1.1 billion yuan. Deployments span automotive giants like BYD and Geely, smart factories, and logistics hubs, with over 500 units already operational by April 10.

Experts Highlight Strategic Edge

Industry analysts praise UBTECH's Co-Agent system, enabling Walker S2's autonomous task planning, tool use, and anomaly handling, as a game-changer for real-world applications. Chief Branding Officer Michael Tam emphasized in a South China Morning Post interview on April 8 that falling component costs and iterative field data from partners like FAW-Volkswagen underpin this tenfold output jump. Observers note this closed-loop model—linking tech development, deployment, and refinement—sets UBTECH apart, fostering ecosystem growth amid global robotics competition.

Ambitious Targets Ahead

Looking forward, UBTECH eyes 10,000 annual units by 2027, with Phase 2 expansions at Liuzhou slated for May rollout. Partner collaborations, including training programs for border and factory operators, signal sustained momentum. As orders diversify beyond manufacturing into public services, UBTECH positions itself to dominate humanoid commercialization through 2026.